2289.HK Live signaler | Maksimer profitt med Getagraph.com

Live Chart Being Loaded With Signals

Commentary (29 apr 2024 @ 07:09):

Stats
Dagens volum	2 500.00
Gjennomsnittsvolum	147 813
Markedsverdi	1.49B
EPS	HKD0 ( 2024-03-29 )
Neste inntjeningsdato	( HKD0 ) 2024-05-20
Last Dividend	HKD0.499 ( 2023-06-29 )
Next Dividend	HKD0 ( N/A )
P/E	27.14
ATR14	HKD0.117 (0.84%)

Charmacy Pharmaceutical Korrelasjon

10 Mest positive korrelasjoner

10 Mest negative korrelasjoner

Visste du det?

Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).

Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.

Charmacy Pharmaceutical Økonomi

Annual	2023
Omsetning:	HKD4.40B
Bruttogevinst:	HKD292.74M (6.65 %)
EPS:	HKD0.480

FY	2023
Omsetning:	HKD4.40B
Bruttogevinst:	HKD292.74M (6.65 %)
EPS:	HKD0.480

FY	2022
Omsetning:	HKD4.18B
Bruttogevinst:	HKD268.61M (6.43 %)
EPS:	HKD0.840

FY	2021
Omsetning:	HKD3.79B
Bruttogevinst:	HKD237.22M (6.25 %)
EPS:	HKD0.221

Financial Reports:

No articles found.

Charmacy Pharmaceutical Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0.949 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)

Charmacy Pharmaceutical Dividend Information - Ex Dividend Junior

Dividend Sustainability Score: 4.03 - low (34.13%) | Divividend Growth Potential Score: 1.533 - No dividend expected

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	HKD0.229	2016-11-14
Last Dividend	HKD0.499	2023-06-29
Next Dividend	HKD0	N/A
Payout Date	0000-00-00
Next Payout Date	N/A
# dividends	9	--
Total Paid Out	HKD2.57	--
Avg. Dividend % Per Year	0.00%	--
Score	1.43	--
Div. Sustainability Score	4.03
Div.Growth Potential Score	1.533
Div. Directional Score	2.78	--

Next Divdend (Est)
(2024-10-07)

HKD0.572 Estimate 3.10 %

Dividend Stability

0.25 Very Poor

Dividend Score

1.43

Pay Frequency

Annually

Yearly Payout

Year	Amount	Yield

Dividend Commentary

The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.

Top 10 dividend Companies for HKSE

Symbol	Title	Last dividend	Frequency	Yearly Dividend
9928.HK	Ex Dividend Junior	2023-06-02	Annually	0.00%
2180.HK	Ex Dividend Knight	2023-07-03	Annually	0.00%
1181.HK	Ex Dividend Knight	2023-09-13	Annually	0.00%
0257.HK	Ex Dividend Junior	2023-09-25	Semi-Annually	0.00%
3888.HK	Ex Dividend Junior	2023-06-02	Annually	0.00%
1755.HK	Ex Dividend Knight	2023-07-03	Annually	0.00%
0798.HK	Ex Dividend Junior	2023-06-20	Annually	0.00%
2338.HK	Ex Dividend Knight	2023-09-28	Semi-Annually	0.00%
1313.HK	Ex Dividend Junior	2023-09-14	Semi-Annually	0.00%
0373.HK	Ex Dividend Junior	2023-05-04	Semi-Annually	0.00%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.0117	1.500	9.77	10.00	[0 - 0.5]
returnOnAssetsTTM	0.0158	1.200	9.47	10.00	[0 - 0.3]
returnOnEquityTTM	0.0877	1.500	-0.136	-0.205	[0.1 - 1]
payoutRatioTTM	0.233	-1.000	7.67	-7.67	[0 - 1]
currentRatioTTM	1.074	0.800	9.63	7.71	[1 - 3]
quickRatioTTM	0.611	0.800	-1.113	-0.890	[0.8 - 2.5]
cashRatioTTM	0.242	1.500	9.77	10.00	[0.2 - 2]
debtRatioTTM	0.393	-1.500	3.46	-5.19	[0 - 0.6]
interestCoverageTTM	0	1.000	-1.111	-1.111	[3 - 30]
operatingCashFlowPerShareTTM	-2.12	2.00	-0.706	-1.412	[0 - 30]
freeCashFlowPerShareTTM	-2.40	2.00	-1.199	-2.40	[0 - 20]
debtEquityRatioTTM	2.13	-1.500	1.469	-2.20	[0 - 2.5]
grossProfitMarginTTM	0.0665	1.000	-2.23	-2.23	[0.2 - 0.8]
operatingProfitMarginTTM	0.0247	1.000	-1.507	-1.507	[0.1 - 0.6]
cashFlowToDebtRatioTTM	-0.179	1.000	-2.11	-2.11	[0.2 - 2]
assetTurnoverTTM	1.356	0.800	4.29	3.43	[0.5 - 2]
Total Score				4.03

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	27.13	1.000	7.36	0	[1 - 100]
returnOnEquityTTM	0.0877	2.50	-0.0877	-0.205	[0.1 - 1.5]
freeCashFlowPerShareTTM	-2.40	2.00	-0.799	-2.40	[0 - 30]
dividendYielPercentageTTM	7.36	1.500	10.00	0	[0 - 0.4]
operatingCashFlowPerShareTTM	-2.12	2.00	-0.706	-1.412	[0 - 30]
payoutRatioTTM	0.233	1.500	7.67	-7.67	[0 - 1]
pegRatioTTM	0	1.500	-3.33	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	-0.0520	1.000	-3.80	0	[0.1 - 0.5]
Total Score				1.533

Charmacy Pharmaceutical

Charmacy Pharmaceutical Co., Ltd. engages in the trading of pharmaceutical products in the People's Republic of China. The company offers western medicines, Chinese patent medicines, healthcare products, and related consulting services to downstream distributors and terminal chemists. It also operates Charmacy e-Medicine, a B2B e-commerce platform to place orders online and make inquiries and payments. The company was formerly known as Chuangmei Pharmaceutical Co., Ltd. and changed its name to Charmacy Pharmaceutical Co., Ltd. in July 2016. Charmacy Pharmaceutical Co., Ltd. was incorporated in 1984 and is headquartered in Shantou, the People's Republic of China.